Estimating the generation time for SARS-CoV-2 transmission using household data in the United States, December 2021 - May 2023
Chan, L. Y. H.; Morris, S. E.; Stockwell, M. S.; Bowman, N. M.; Asturias, E.; Rao, S.; Lutrick, K.; Ellingson, K. D.; Nguyen, H. Q.; Maldonado, Y.; McLaren, S. H.; Sano, E.; Biddle, J. E.; Smith-Jeffcoat, S. E.; Biggerstaff, M.; Rolfes, M. A.; Talbot, H. K.; Grijalva, C. G.; Borchering, R. K.; Mellis, A. M.; RVTN-Sentinel Study Group,
Show abstract
BackgroundGeneration time, representing the interval between infection events in primary and secondary cases, is important for understanding disease transmission dynamics including predicting the effective reproduction number (Rt), which informs public health decisions. While previous estimates of SARS-CoV-2 generation times have been reported for early Omicron variants, there is a lack of data for subsequent sub-variants, such as XBB. MethodsWe estimated SARS-CoV-2 generation times using data from the Respiratory Virus Transmission Network - Sentinel (RVTN-S) household transmission study conducted across seven U.S. sites from December 2021 to May 2023. The study spanned three Omicron sub-periods dominated by the sub-variants BA.1/2, BA.4/5, and XBB. We employed a Susceptible-Exposed-Infectious-Recovered (SEIR) model with a Bayesian data augmentation method that imputes unobserved infection times of cases to estimate the generation time. FindingsThe estimated mean generation time for the overall Omicron period was 3.5 days (95% credible interval, CrI: 3.3-3.7). During the sub-periods, the estimated mean generation times were 3.8 days (95% CrI: 3.4-4.2) for BA.1/2, 3.5 days (95% CrI: 3.3-3.8) for BA.4/5, and 3.5 days (95% CrI: 3.1-3.9) for XBB. InterpretationOur study provides estimates of generation times for the Omicron variant, including the sub-variants BA.1/2, BA.4/5, and XBB. These up-to-date estimates specifically address the gap in knowledge regarding these sub-variants and are consistent with earlier studies. They enhance our understanding of SARS-CoV-2 transmission dynamics by aiding in the prediction of Rt, offering insights for improving COVID-19 modeling and public health strategies. FundingCenters for Disease Control and Prevention, and National Center for Advancing Translational Sciences.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- High household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color 96%
- Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study 94%
- Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational household transmission study 94%
Similar papers in this journal
- Vaccine-induced antibody level predicts the clinical course of breakthrough infection of COVID-19 caused by delta and omicron variants: a prospective observational cohort study 93%
- Genomic surveillance of SARS-CoV-2 in a university community: insights into tracking variants, transmission, and spread of Gamma (P.1) variant 93%
- Assessment of COVID-19 intervention strategies in the Nordic countries using genomic epidemiology 93%
Similar papers in this journal
- SARS-CoV-2 virus dynamics in recently infected people – data from a household transmission study 94%
- Lower levels of household transmission of SARS-CoV-2 VOC Omicron compared to Wild-type: an interplay between transmissibility and immune status 94%
- The impact of co-circulating pathogens on SARS-CoV-2/COVID-19 surveillance: How concurrent epidemics may decrease true SARS-CoV-2 percent positivity 93%
Similar papers in this journal
- Novel application of capture-recapture methods to estimate the completeness of contact tracing during a large outbreak of Ebola Virus Disease, Democratic Republic of Congo, 2018-2020 95%
- From Delta to Omicron: analysing the SARS-CoV-2 epidemic in France using variant-specific screening tests (September 1 to December 18, 2021) 94%
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study 94%
Similar papers in this journal
- Impact of interventions on mpox transmission during the 2022 outbreak in Canada: a mathematical modeling study of three different cities 93%
- Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave 93%
- SARS-CoV-2 infections in 171 countries and over time 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.